Babak Peyami Joins Karo’s Corporate Management Team as new Head of Digital Commerce
Karo Healthcare announces changes to its Corporate Management Team. Robin List transitions to an advisory role and Babak Peyami is promoted to drive Karo’s digital commerce activities.
Babak joined Karo in 2021 as part of the Sylphar acquisition and brings extensive digital expertise to our organization. Alongside Arash Peyami, Babak co-founded Nutravita, a digital-first brand that has become Karo's second-largest brand under their joint leadership. Arash will continue to play a vital role in driving the digital business together with Babak, ensuring the establishment of an optimal digital commercial infrastructure within Karo Healthcare and both will report to Christoffer Lorenzen, CEO.
“I am thrilled to embark on this new chapter and to be part of a dynamic team that values innovation and embraces the digital landscape.” says Babak Peyami.
In his new role as Head of Digital Commerce, Sales and Business Development, Babak will spearhead our sales efforts on platforms like Amazon and other third-party channels. Moreover, he will take charge of managing our direct-to-consumer business, oversee our digital marketing efforts, and provide guidance and support for our e-commerce and e-pharmacy initiatives across local markets.
“At Karo Healthcare, we are lucky to have incredibly talented people. We believe in developing our people by giving them new opportunities and responsibilities. Babak is an example of how talents can develop and grow when given such opportunities. He has responded in an exemplary manner to increasing levels of responsibility and is a real trailblazer within Karo when it comes to digital commerce. Together with Arash Peyami and our excellent team of talented digital commerce individuals, Babak will help us advance our performance in digital consumer healthcare channels.” says Christoffer Lorenzen, CEO at Karo.
We would also like to take this opportunity to acknowledge Robin List, the founder and previous CEO of Sylphar, who has played an instrumental role in our organization during the transition period following the acquisition in 2021. With dedication and commitment, Robin has made significant contributions to our team. As he steps down from his current role, Robin will continue to serve as an advisor to both the CEO and the Corporate Management Team. We thank Robin for his invaluable contributions and look forward to his continued guidance.
For further information, please contact:
Christoffer Lorenzen, CEO, +46 735 017 620, christoffer.lorenzen@karo.com
Lisa Westerdahl, Corporate Communication, +46 733 297 004, lisa.westerdahl@karo.com
About Karo Healthcare
Karo Healthcare is a leading European consumer healthcare company with the purpose of delivering "Smart choices for everyday healthcare", empowering people to live life to the fullest. Our products are available in more than 90 countries and include trusted original brands such as E45®, Pevaryl®, Proct®, AlphaFood, Nutravita, Flux®, Locobase®, Multi-Gyn® and Paracet®. More than 400 colleagues work out of the headquarters in Stockholm and its international hubs. Karo Healthcare is since 2019 owned by EQT.
The information was submitted for publication by the contact person set out above, at CET 13:00 on 3 July, 2023.